The TLR4 agonist monophosphoryl lipid A drives broad resistance to infection via dynamic reprogramming of macrophage metabolism

Monophosphoryl lipid A (MPLA) is a clinically utilized toll-like receptor (TLR) 4 agonist that has been found to drive non-specific resistance to infection for up to two weeks. However, the molecular mechanisms conferring protection are not well understood. Here, we found that MPLA prompts resistanc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol
Autors principals: Fensterheim, Benjamin A., Young, Jamey D., Luan, Liming, Kleinbard, Ruby R., Stothers, Cody L., Patil, Naeem K., McAtee-Pereira, Allison G., Guo, Yin, Trenary, Irina, Hernandez, Antonio, Fults, Jessica B., Williams, David L., Sherwood, Edward R., Bohannon, Julia K.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5964009/
https://ncbi.nlm.nih.gov/pubmed/29686054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars